U.S. Markets open in 50 hrs, 29 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 40.00 09:39 AM EDT | |
|---|---|---|
| Day High | 41.37 10:26 AM EDT |
|
| Range | 1.37 |
| Volume | 283,468 | |
|---|---|---|
| 30-Day Avg Vol | 621,000 |
|
| Difference | -54.35% |
| Market Cap | 7.52 B | |
|---|---|---|
| Mkt Cap Chg | -197.96 M |
| Shares Out | 186.76 M | |
|---|---|---|
| % Shrs Traded | 0.15% | |
| 1yr EPS Est | 2.432 |
| 52-Wk Low | 31.66 3/11/09 | |
|---|---|---|
| 52-Wk High | 55.50 8/12/08 |
|
| Range | 23.84 |
| Prev Close | 41.37 7/1/09 | |
|---|---|---|
| Today's Open | 40.48 | |
| Change | -2.15% |
| Dividend (TTM) | 0.29724 | |
|---|---|---|
| Div Yield (TTM) | 0.72% | |
| Ex-Div Date | 03/11/2009 | |
| Div Date | 04/08/2009 |
|
| Short Interest | 3.58 M |
| Revenue (LFY) | 3.02 B | |
|---|---|---|
| Earnings (LFY) | 156.00 M | |
| Earnings (MRQ) | 179.89 M | |
| Next Earn Est | 0.487 | |
| Next Earnings |
|
|
| EPS (TTM) | -0.14896 | |
| 1yr EPS Growth | -44.85% |
| P/E Ratio (TTM) | 27.99 | |
|---|---|---|
| P/E Ratio (Fwd) | 16.00 | |
| PEG Ratio | 4.29 | |
| Return on Equity | 5.09 | |
| Beta | 0.94 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
CNBC Video
Shire's drugs help patients pay attention and stay on task. The specialty drug company, the UK's third largest, has a roster that includes attention deficit hyperactivity disorder (ADHD) treatments Vyvanse ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.487 N/A | — — |
—
—
|
| Last Quarter | 1.065 3/31/09 | 1.28 3/31/09 |
0.215
Beat
|
| 2 Quarters Ago | 1.016 12/31/08 | 1.01 12/31/08 |
-0.006
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 688.72 M | 3.02 B |
| Gross Profit | 575.11 M | 2.49 B |
| Operating Income | 146.70 M | 500.90 M |
| Net Income | 179.89 M | 156.00 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts